Supplementary Figure 2 from Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
MYCN binding to GP2 and ODC1 and enhancer window ATAC.
Fields of Study & Subjects
Neuroblastoma Research and Treatments
Glioma Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers
Publication details
- Publication date
- 2 April 2026
- Language
- EN